← Back to headlines
Vertex Tops Profit Estimates as New Cystic Fibrosis Drug Sales Surge
Vertex Pharmaceuticals exceeded profit estimates, driven by a significant surge in sales of its new cystic fibrosis drug. The strong performance highlights the drug's market success.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Seattle Times and Newsday File Copyright Lawsuits Against OpenAI and Microsoft
1h ago
OpenAI agents reportedly hijack German website during spring AI security breach
1h ago
Panama Canal Reduces Daily Ship Transits Amid El Niño Drought
1h ago
Anthropic Delays IPO to Mid-October Amid Bank Selection Process
2h ago